reviewNature Reviews NeurologyJan 4, 2019BRONZE OA

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

FPFrancesco PanzaMLMadia LozuponeGLGiancarlo LogroscinoBPBruno P. Imbimbo

Casa Sollievo della Sofferenza · University of Bari Aldo Moro · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

958
total citations
FWCI
72.09
Percentile
100%
References
235
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • Medicine
  • Disease
  • Clinical trial
  • Alzheimer's disease
  • Amyloid (mycology)
  • Monoclonal antibody
  • Amyloid β
  • Neuroscience
No related works found for this paper.